Research and Development

Recently in the UK there has been a move towards risk-based inspection programmes.  The scope, frequency and depth of MHRA …

I am always guided by the motto of the Royal Society, ‘Nullius in Verba’. This means, with typical Latin brevity: …

Singapore has reinforced its position as a major pharmaceutical hub for the Asia-Pacific region with the news that Merck is …

BMS has made three changes to its senior management with Giovanni Caforio promoted to president of US pharmaceuticals and Charles …

 

Merck Serono has returned the rights to the Parkinson’s disease drug safinamide back to Newron. The decision comes after the …

Abbott’s new spin-off pharma firm could attract a lot of attention from big pharma looking to sure up their portfolios. …

The ABPI has warned that the UK must continue to attract investment for research, or risk being superseded by emerging …

Abbott’s management has decided to split the company into two separate entities in order to give shareholders a ‘distinct investment …

Rumours are gathering pace that GlaxoSmithKline may launch a takeover bid for struggling US firm Human Genome Sciences. British tabloid …

An injectable version of Roche’s breast cancer drug Herceptin compares favourably to the standard intravenous infusion, according to new research. …

The inclusion of the manufacturer’s address on the labels and instructions for use is an Essential Requirement according to the …

Holders wishing to cancel their authorisations, registrations and licences are required to notify the MHRA by 31 December 2011 to …

Results from GSK’s malaria vaccine trial have excited observers after it reduced the risk of the disease by half. Data …

The European Court of Justice has ruled that stem cells cannot be patented, representing a major blow to research in …